In the past two weeks, U.S. public health authorities have skirted normal procedures and announced two major policy changes ...

U.S. public health authorities have skirted normal procedures and announced two major policy changes that will likely reduce ...

The FDA’s decision comes at a time when the number of cases of COVID variant NB.1.8.1 have been rising globally, which ...

The new mRNA vaccine encodes the receptor-binding domain and the N-terminal domain of the SARS-CoV-2 spike protein ...

Despite uncertainties arising from new FDA policies around COVID-19 vaccines, Moderna has cleared the agency's desk with its ...

House appropriators advanced a bill to fund the FDA for fiscal 2026 on a party-line vote out of a subcommittee Thursday — but ...

FDA's top vaccine official Vinay Prasad, MD, MPH, and others at the agency explained the recent pause on the use of the ...

"Political directives should not prevent individuals from seeking safe and effective care that they desire and deserve," ...

His rise to national prominence came during the COVID ... of Prasad argue that his commitment to scientific rigor and transparency is precisely what the agency needs. “Vinay is willing to ...

Moderna’s next-generation COVID-19 vaccine earns FDA approval for high-risk groups only. Learn what this could mean for ...

Unpredictable and politically driven regulatory approaches cultivate an environment of enormous uncertainty for vaccine ...